DIG-IT, a new EFA project on the asthma and COPD patient’s digital journey
The world is undergoing a digital transition that is changing our societies and economies at an unprecedented speed, accelerated by the COVID-19 pandemic....
European Lung Health Group launches a Breathe Vision for 2030
Throughout most of 2020, EFA and eight other organisations representing patients and healthcare professionals came together as the informal European Lung...
EFA 2021 Project: DIGIT
The world is undergoing a digital transition that is changing our societies and economies at an unprecedented speed, accelerated by the COVID-19 pandemic.
Digitalisation...
PRESS RELEASE: World Meteorological Day 2021
BRUSSELS, 23/03/2021 - On the occasion of World Meteorological Day 23 March 2021, the European Academy of Allergy Asthma and Clinical Immunology (EAACI),...
EFA patients insist on the need to improve air quality during this decisive legislative year
On paper, 2021 seems to have it all: a brand new Zero Air Pollution Action Plan, the revision of the air quality framework, the update of the World Health...
EFA 2021 Project: Atopic Eczema Consensus Europe
In the past years, EFA has been vocal in advocating change for all people living with atopic eczema in Europe. One of our most relevant contributions has...
The EU prepares the field to address climate-change related disease: launch of the Climate Adaptation Strategy
The European Commission adopted its Climate Adaptation Strategy on 24 February, which outlines how the European Union can adapt to the consequences of...
Europe's Beating Cancer Plan will bring enormous benefits for respiratory health
On 3rd February, the European Commission published its Beating Cancer Plan a signature programme that devices the commitment by the European Union to coordinate...
EFA response to the Commission proposal for a strengthened role for the European Medicines Agency
Following the EU’s plan for a European Health Union (EHU), the European Commission Directorate General For Health and Food Safety (DG SANTE) opened a...
JOINT STATEMENT: European lung health collaboration calls for frontline workers and lung disease patients to be prioritised in EU’s COVID-19 vaccines roll out
(pdf version below)
December 21st 2020 - COVID-19 has had a profound impact on the respiratory community. The newly formed European lung health group...
Save the Date: European Parliament MEP Lung Health Group event “Towards a European Health Union - BREATHE Vision for the future”
European Parliament MEP Lung Health Group event “Towards a European Health Union - BREATHE Vision for the future”, January 27, 10h00-11h15 CET
The...
EU adopts biggest ever Health budget and envisages a European Health Union
Following months of tense negotiations, on 15 December the European Parliament and the Council agreed on the terms of the 4th EU Health Programme (EU4Health),...
EFA President Mikaela Odemyr spoke at EAACI's Second Strategic Forum on Allergic Diseases and Asthma
EFA President Mikaela Odemyr spoke at the Second Strategic Forum on Allergic Diseases and Asthma organised by the European Academy of Allergy...
MEP Lung Health Group places respiratory health at heart of the European Parliament
The MEP Lung Health group is an informal platform for policymakers and European level health professionals and patient organisations, including EFA, working...
EP Interest Group on Allergy and Asthma: Launch of the Youth Parliament's recommendations
On Thursday 10 December, the European Parliament Interest Group on Allergy & Asthma hosted a digital launch for guidelines created by the the Allergy...
EFA Allergy and Respiratory Patients Conference: Delivering patient-centric care through innovation and digitalisation
While 2020 has been a challenging year, it has also shown the potential of a more digitalised world, particularly in healthcare and the management of chronic...
EFA’s evaluation of the 3rd EU Health Programme 2014-2020: insufficient to protect our health
As the voice for over 200 million people living with allergy and airways diseases in Europe, EFA participated in the European Commission consultation to...
EFA brings the patient perspective to the European Commission preliminary opinion on electronic cigarettes
The Scientific Committee on Health, Environmental and Emerging Risks (SCHEER), organised a public consultation on its preliminary opinion on electronic...
EFA discusses Qualitative Risk Assessment for food allergens at ILSI event
On 29 October, EFA participated in the digital event on Qualitative Risk Assessment organised by the International Life Sciences Institute (ILSI). It was...
Chemicals and health: EFA highlights from the ECHA Open Forum 2020
As Accredited Stakeholder to the European Chemicals Agency (ECHA), EFA participated in the 2020 Joint Forum-BPRS (Biocidal Products Regulation Subgroup)...